KR950023404A - 5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제 - Google Patents

5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제 Download PDF

Info

Publication number
KR950023404A
KR950023404A KR1019940001240A KR19940001240A KR950023404A KR 950023404 A KR950023404 A KR 950023404A KR 1019940001240 A KR1019940001240 A KR 1019940001240A KR 19940001240 A KR19940001240 A KR 19940001240A KR 950023404 A KR950023404 A KR 950023404A
Authority
KR
South Korea
Prior art keywords
hepatitis
furfural
hydroxymethyl
therapeutics containing
hepatitis therapeutics
Prior art date
Application number
KR1019940001240A
Other languages
English (en)
Other versions
KR100285586B1 (ko
Inventor
김정민
김순하
이우길
Original Assignee
성재갑
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 엘지화학 filed Critical 성재갑
Priority to KR1019940001240A priority Critical patent/KR100285586B1/ko
Publication of KR950023404A publication Critical patent/KR950023404A/ko
Application granted granted Critical
Publication of KR100285586B1 publication Critical patent/KR100285586B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 B형 간염 표면항원 생성 억제효과 및 B형 간염 바이러스의 DNA 생성 억제 효과를 나타내는 5-히드록시메틸-2-푸르푸랄을 활성성분으로 포함하는 B형 간염 치료제를 제공한다.

Description

5-히드록시메틸-2-푸르푸랄을 함유하는 비(B)형 간염 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 5-히드록시메틸-2-푸르푸랄과 표준품인 Ara-AMP를 비교정량 PCR방법으로 B형 간염 바이러스 DNA 생성 억제 정도를 비교 분석한 결과를 나타낸 것이다.

Claims (2)

  1. 5-히드로시메틸-2-푸르푸랄을 활성성분으로 포함하는 B형 간염 치료제.
  2. 제1항에 있어서, 5-히드록시메틸-2-푸르푸랄이 천연약제 유래, 식품 유래 또는 화학합성된 것인 B형 간염 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940001240A 1994-01-25 1994-01-25 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제 KR100285586B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940001240A KR100285586B1 (ko) 1994-01-25 1994-01-25 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940001240A KR100285586B1 (ko) 1994-01-25 1994-01-25 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제

Publications (2)

Publication Number Publication Date
KR950023404A true KR950023404A (ko) 1995-08-18
KR100285586B1 KR100285586B1 (ko) 2001-04-02

Family

ID=37514432

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940001240A KR100285586B1 (ko) 1994-01-25 1994-01-25 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제

Country Status (1)

Country Link
KR (1) KR100285586B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103202804A (zh) * 2013-02-22 2013-07-17 广东先强药业股份有限公司 一种单磷酸阿糖腺苷注射液及其制备方法

Also Published As

Publication number Publication date
KR100285586B1 (ko) 2001-04-02

Similar Documents

Publication Publication Date Title
CA2173328A1 (en) HIV Protease Inhibitors
DE69202207T2 (de) Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
PT93393A (pt) Processo para a preparacao de vacinas e de agentes de diagnostico que contem regioes imunogenicas de proteina e7do virus do papiloma humano do tipo 16 ou anticorpos suscitados contra estas regioes
KR890015742A (ko) 이병치료용 국소 제제
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
ES2184764T3 (es) Complejos de inclusion de taxol o taxotere o extracto de taxus formados por ciclodextrinas, su preparacion y utilizacion.
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
ES2173923T3 (es) Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente.
WO2001097824A3 (de) Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
KR950023404A (ko) 5-히드록시메틸-2-푸르푸랄을 함유하는 비(b)형 간염 치료제
DE69309790T2 (de) Cyclopentanperhydrophenanthren-17-beta-(3-Furyl)-3-Derivate und pharmazeutische Präparate davon, zur Behandlung von Kardiovaskulär-Erkrankungen
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
DE69528044D1 (de) Synthese von optisch reiner 4-aryl-2-hydroxytetronic
KR960006920A (ko) 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도
NO900545L (no) Krydder.
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
WO1988007367A3 (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
DZ1748A1 (fr) Sel de lysine du 6-chloro-5-fluoro-3-(2-thénoyl)-2-oxindole-1-carboxamide et composition pharmaceutique le contenant.
KR950008683A (ko) 다중약제내성 1 유전자 및 b형 간염바이러스(hbv) 유전자를 발현하는 인체 간암 세포주
KR960006921A (ko) 약학 조성물
SE9702993D0 (sv) Anti-mikrobial komposition
KR970019821A (ko) 송진을 함유한 치약 제조 방법

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20031219

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee